Another Coronary Stent for Patients at High Bleeding Risk

Davide Capodanno, Davide Capodanno

No abstract available

Keywords: coronary stent; high bleeding risk.

Conflict of interest statement

Funding Support and Author Disclosures Dr Capodanno has received consulting and speaker fees from Amgen, Boehringer Ingelheim, Biotronik, Daiichi-Sankyo, and Sanofi outside the present work.